Sera Prognostics, Inc.

Healthcare · Medical Devices · United States

Last price 2.04 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 80.48M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Sera Prognostics, Inc., a women’s health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive an...